Although there was statistically significant publication bias for the BRAF prevalence analyses, the addition of hypothetical “missing” studies did not significantly change the estimate of BRAF prevalence in right‐ or left‐sided colon cancers. This evidence concerns the gene BRAF and malignant colon neoplasm.